Connect with us

Hi, what are you looking for?

Jewish Business News


DiskOnKey Inventor Ventured $2 Million For Keyboard With A Screen And Lost The Lot

Dov Moran closes smart keyboard co KeyView.

Dov Moran

The DiskOnKey inventor, Dov Moran, has told “Globes” that he has closed KeyView, 18 months after launching the start-up, which offered a smart computer keyboard with a color screen, called SmartType. The serial entrepreneur was confident of KeyView’s success, but it failed to catch on.
Moran invested $2 million in KeyView, which was founded in 2010, and had nine employees. Moran served as chairman.
“Thousands of people around the world bought the product. There was feedback from people who said that it saved their lives, but I wasn’t satisfied with it as it was, ” said Moran. “Besides, I concluded that the home desktop market would disappear in a few years. Instead of starting development of a new product, I decided to close shop. Sometimes, you have to know when to say, ‘enough’.”

The SmartType, which cost NIS 400, included a screen on its upper side, which could be seen while typing, thereby avoiding typos, changes in language, and misspellings for people unable to touch type. The color screen also showed new email titles, the time, and the weather.

Dov Moran was founder and chairman of msystems, which invented the DiskOnKey, before being acquired by SanDisk Corporation (Nasdaq:SNDK) for $1.6 billion. He also was founder and chairman of modu, which developed the world’s smalled mobile phone, but failed commercially.

SmartType dov moran


Published by Globes [online], Israel business news –

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.